13F

Stock

Anika Therapeutics, Inc.

ANIK · held by 2 managers

Reported value

$374.5K

Holders

2

+0 new · −0 exited

Holders’ est. mark

−$124.6K

Price effect on 1 books still in the name

Largest holder

$374.4K

BARCLAYS PLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
BARCLAYS PLC35.4K$374.4K−$124.6KCut−$46.6K
Essential Partners LLC5$53Held

Positions as of Q2 2025. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.